Decline of Admission for Acute Coronary Syndromes and Acute Cardiovascular Conditions during COVID-19 Pandemic in Veneto Region.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 28 07 2022
revised: 22 08 2022
accepted: 27 08 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Background: The present study aimed to examine longitudinal trends in hospitalizations for acute coronary syndrome (ACS) before and during the COVID-19 pandemic, by reviewing the data from 13 hospitals of the Veneto Region, in the north-east of Italy. Methods: We performed a multicenter, retrospective analysis including all the consecutive patients presenting with ACS and other acute cardiovascular (CV) conditions (defined as heart failure, arrhythmias, cardiac arrest and venous thromboembolism) hospitalized in 13 different hospitals of the Veneto Region covering a population of 2,554,818 inhabitants, during the first (between 15 March 2020 and 30 April 2020) and second (between 15 November 2020 and 30 December 2020) COVID-19 pandemic waves (the 2020 cohort). Data were compared with those obtained at the same time-windows of years 2018 and 2019 (the historical cohorts). Results: Compared to the historical cohorts, a significant decrease in the number of ACS cases was observed in 2020 (−27.3%, p = 0.01 and −32%, p < 0.001, comparing 2018 versus 2020 and 2019 and 2020, respectively). The proportion of patients hospitalized for acute CV conditions decreased during the first and second wave COVID-19 pandemic when compared to the historical cohorts (−36.5%, p < 0.001 and −40.6%, p < 0.001, comparing 2018 versus 2020 and 2019 and 2020, respectively). Pearson’s correlation evidenced a significant inverse relationship between the number of COVID-19 cases and both ACS hospital admissions (r = −0.881, p = 0.005) and hospitalizations for acute CV conditions (r = −0.738, p = 0.01), respectively. Conclusions: The decrease in hospitalizations for ACS and other acute CV conditions will strongly affect future patients’ management since undiagnosed nonfatal CV events represent a source of increased (and unknown) CV morbidity and mortality.

Identifiants

pubmed: 36146731
pii: v14091925
doi: 10.3390/v14091925
pmc: PMC9502380
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Coll Cardiol. 2020 Jul 21;76(3):280-288
pubmed: 32470516
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
J Am Heart Assoc. 2020 Jul 7;9(13):e017122
pubmed: 32441548
Z Gesundh Wiss. 2022;30(8):1985-1993
pubmed: 35004128
Eur Heart J. 2019 May 21;40(20):1590-1596
pubmed: 30860255
Clin Res Cardiol. 2020 Dec;109(12):1500-1506
pubmed: 32749557
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
High Blood Press Cardiovasc Prev. 2021 Sep;28(5):439-445
pubmed: 34173942

Auteurs

Marco Zuin (M)

Division of Cardiology, West Vicenza General Hospital, Via del Parco 1, 36071 Arzignano, Vicenza, Italy.

Giacomo Mugnai (G)

Division of Cardiology, West Vicenza General Hospital, Via del Parco 1, 36071 Arzignano, Vicenza, Italy.

Alberto Zamboni (A)

Division of Cardiology, Legnago General Hospital, 37045 Legnago, Verona, Italy.

Edlira Zakja (E)

Division of Cardiology, San Donà General Hospital, 30027 San Donà di Piave, Venezia, Italy.

Roberto Valle (R)

Division of Cardiology, Chioggia General Hospital, 30015 Chioggia, Venezia, Italy.

Giovanni Turiano (G)

Division of Cardiology, San Donà General Hospital, 30027 San Donà di Piave, Venezia, Italy.

Sakis Themistoclakis (S)

Division of Cardiology, All'Angelo Hospital, 30174 Mestre, Venezia, Italy.

Daniele Scarpa (D)

Division of Cardiology, Santi Giovanni & Paolo Hospital, 30122 Venezia, Venezia, Italy.

Salvatore Saccà (S)

Division of Cardiology, Mirano General Hospital, 30035 Mirano, Venezia, Italy.

Loris Roncon (L)

Department of Cardiology, Rovigo General Hospital, 45100 Rovigo, Rovigo, Italy.

Francesca Rizzetto (F)

Division of Cardiology, Verona University Hospital, 37100 Verona, Verona, Italy.

Paola Purita (P)

Division of Cardiology, Mirano General Hospital, 30035 Mirano, Venezia, Italy.

Angela Polo (A)

Division of Cardiology, San Bassiano Hospital, 36061 Bassano, Vicenza, Italy.

Ivan Pantano (I)

Division of Cardiology, Chioggia General Hospital, 30015 Chioggia, Venezia, Italy.

Antonio Mugnolo (A)

Division of Cardiology, Legnago General Hospital, 37045 Legnago, Verona, Italy.

Giulio Molon (G)

Division of Cardiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar, Verona, Italy.

Samuele Meneghin (S)

Division of Cardiology, Padua University Hospital, 35128 Padova, Padova, Italy.

Daniela Mancuso (D)

Division of Cardiology, Padua University Hospital, 35128 Padova, Padova, Italy.

Micaela Lia (M)

Division of Cardiology, Verona University Hospital, 37100 Verona, Verona, Italy.

Giuseppe Grassi (G)

Division of Cardiology, Santi Giovanni & Paolo Hospital, 30122 Venezia, Venezia, Italy.

Ada Cutolo (A)

Division of Cardiology, All'Angelo Hospital, 30174 Mestre, Venezia, Italy.

Fabio Chirillo (F)

Division of Cardiology, San Bassiano Hospital, 36061 Bassano, Vicenza, Italy.

Paolo Bozzini (P)

Division of Cardiology, Fracastoro Hospital, 37020 San Bonifacio, Verona, Italy.

Stefano Bonapace (S)

Division of Cardiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar, Verona, Italy.

Maurizio Anselmi (M)

Division of Cardiology, Fracastoro Hospital, 37020 San Bonifacio, Verona, Italy.

Gianluca Rigatelli (G)

Division of Cardiology, Madre Teresa Hospital, 35043 Padova, Schiavonia, Italy.

Claudio Bilato (C)

Division of Cardiology, West Vicenza General Hospital, Via del Parco 1, 36071 Arzignano, Vicenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH